To determine the relative bioavailability of different formulations of AZD9291 and the effect of food.

Study identifier:D5160C00005

ClinicalTrials.gov identifier:NCT01951599

EudraCT identifier:N/A

CTIS identifier:N/A

Study Complete

Official Title

A Phase I, Open-label, Single-center, Sequential Design Study in Healthy Volunteers to Determine the Relative Bioavailability of Different Oral Formulations of AZD9291 and the Effect of Food

Medical condition

Healthy Volunteers

Phase

Phase 1

Healthy volunteers

Yes

Study drug

AZD9291

Sex

Male

Actual Enrollment

35

Study type

Interventional

Age

18 Years - 55 Years

Date

Study Start Date: 09 Oct 2013
Primary Completion Date: 04 Jun 2014
Study Completion Date: 04 Jun 2014

Study design

Allocation: N/A
Endpoint Classification: Bio-availability Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Basic Science

Verification:

Verified 01 Mar 2017 by AstraZeneca

Sponsors

AstraZeneca

Collaborators

-

Inclusion and exclusion criteria